Capricor Therapeutics Inc (NASDAQ:CAPR)

2.91
BATS BZX Real-Time Price
As of 1:24pm ET
 -0.06 / -2.02%
Today’s Change
2.80
Today|||52-Week Range
8.22
-24.61%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$88.2M

Company Description

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Contact Information

Capricor Therapeutics, Inc.
10865 Road to the Cure
San Diego California 92121
P:(858) 727-1755
Investor Relations:
1310

Employees

Shareholders

Mutual fund holders6.29%
Other institutional3.90%
Individual stakeholders2.14%

Top Executives

Linda MarbánPresident, Chief Executive Officer & Director
Anthony J. BergmannChief Financial Officer
Kristi A. H. ElliottChief Science Officer
Karen G. KrasneySecretary, Executive VP & General Counsel
Xavier AvatChief Business Officer